Scientifically groundless regulations could undercut the potential of gene-edited crops, much as they have with GMOs.

There have been no reports of health or environmental harm in other locations where genetically modified mosquitoes have been introduced over the last decade.

The FDA recently cleared the way for marketing of the genetically modified product. Texas A&M’s Keerti Rathore speaks with The Scientist about why and how it was developed.

All six calves inherited the gene for preventing horn growth, but four also got a piece of the plasmid used to introduce the sequence to their dad—complicating regulatory approval.

The biotech Oxitec had released the genetically engineered insects with the hope that they would breed with wild populations and produce offspring that die young. But that’s not always happening.

The large-scale experiments aim to test how the technology would fare in the wild, if deployed to knock down populations of the pests.

A recent meeting about the disconnect between scientific and public beliefs points to ways researchers can improve how they communicate with skeptics.

While farmers have the green light to grow the genetically engineered plant, FDA approval is still needed before the seeds are sold as food.

Unlike judges in the European Union, a government panel in Japan says transgenic modification and genome editing are not the same.

The European Court of Justice has decided that organisms made with precision techniques such as CRISPR will be subject to the same rules as transgenic plants or animals.

An analysis of 40 years of data also finds declines in pest populations after the introduction of the GM crop.

RT and Sputnik publish stories about GMOs more often than US outlets, and typically portray them in a negative light.

Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.

Plantings of non-GM refuges counter the development of resistance.

The EPA is now in charge of regulating the use of Oxitec’s strain of Aedes aegypti, genetically engineered to reduce populations of the insects.

In an effort to prevent the spread of Zika virus, Harris County officials are in discussions with Oxitec to release insects engineered to produce short-lived offspring.

On Tuesday, shareholders at the agribusiness giant approved the $66 billion deal with the European pharmaceutical firm.

Tweaks to a transformation protocol in 1986 cemented the little plant's mighty role in plant genetics research.